Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC.

Saved in:
Bibliographic Details
Title: Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC.
Authors: Selke, Janne1 (AUTHOR), Dzierma, Yvonne1,2 (AUTHOR), Manda, Katrin1 (AUTHOR), Hildebrandt, Guido1 (AUTHOR), Frerker, Bernd1 (AUTHOR), Kalata, Paul1 (AUTHOR), Ackermann, Christin2 (AUTHOR), Bock, Felix1 (AUTHOR) felix.bock@med.uni-rostock.de
Source: Current Oncology. Jun2026, Vol. 33 Issue 6, p351. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 194912127
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Selke%2C+Janne%22">Selke, Janne</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dzierma%2C+Yvonne%22">Dzierma, Yvonne</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Manda%2C+Katrin%22">Manda, Katrin</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hildebrandt%2C+Guido%22">Hildebrandt, Guido</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Frerker%2C+Bernd%22">Frerker, Bernd</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kalata%2C+Paul%22">Kalata, Paul</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ackermann%2C+Christin%22">Ackermann, Christin</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bock%2C+Felix%22">Bock, Felix</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> felix.bock@med.uni-rostock.de</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Current+Oncology%22">Current Oncology</searchLink>. Jun2026, Vol. 33 Issue 6, p351. 15p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194912127
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/curroncol33060351
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 15
        StartPage: 351
    Titles:
      – TitleFull: Real-World Survival Outcomes Following Chemoradiotherapy with or Without Durvalumab in PD-L1-Defined Subgroups of Stage III Unresectable NSCLC.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Selke, Janne
      – PersonEntity:
          Name:
            NameFull: Dzierma, Yvonne
      – PersonEntity:
          Name:
            NameFull: Manda, Katrin
      – PersonEntity:
          Name:
            NameFull: Hildebrandt, Guido
      – PersonEntity:
          Name:
            NameFull: Frerker, Bernd
      – PersonEntity:
          Name:
            NameFull: Kalata, Paul
      – PersonEntity:
          Name:
            NameFull: Ackermann, Christin
      – PersonEntity:
          Name:
            NameFull: Bock, Felix
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: Jun2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 11980052
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Current Oncology
              Type: main
ResultId 1